INKON Life Technology Co., Ltd. (SHE:300143)

Market Cap	8.75B +32.1%
Revenue (ttm)	1.69B +5.9%
Net Income	119.72M +34.6%
EPS	0.17 +23.2%
Shares Out	743.29M
PE Ratio	70.98
Forward PE	63.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,330,180
Average Volume	9,292,488
Open	10.78
Previous Close	10.81
Day's Range	10.76 - 12.68
52-Week Range	8.12 - 14.38
Beta	0.88
RSI	57.10
Earnings Date	Mar 28, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 2,207
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300143

Financial Performance

In 2024, INKON Life Technology's revenue was 1.56 billion, an increase of 6.01% compared to the previous year's 1.47 billion. Earnings were 115.42 million, an increase of 14.92%.